Trusted Resources: Evidence & Education
Scientific literature and patient education texts
The effects of relaxation intervention on pain, stress, and autonomic responses among adults with sickle cell pain in the outpatient setting
source: The Journal of Pain
year: 2018
authors: M. Ezenwa, Y. Yao, M. Nguyen, M. Mandernach, C. Hunter, S. Yoon, A. Amador, A. Sylvera, R. Lamonge, D. Lyon, D. Wilkie
summary/abstract:Pain is the major complication for the approximately 100,000 individuals with sickle cell disease (SCD) in the United States. Although opioid analgesics are the mainstay therapy for SCD pain, little is known about the use of self-managed modalities (e.g., relaxation) and the effects of relaxation on pain, stress, and autonomic responses in patients with SCD.
This pre-post randomized controlled trial was conducted to: 1) determine protocol feasibility: (a) issues of Pentablet computer use for relaxation intervention delivery; (b) acceptability of study procedures; and (c) percentage of missing data); and 2) estimate the size of the relaxation intervention effects on pain and stress and physiologic markers of relaxation (respiration, pulse, and skin temperature [mediators]).
Patients (N = 30, mean age 34.9 ± 10.4 years [22–59 years], 100% Non-Hispanic, 53% male) enrolled between June 2016 and March 2017 were randomized to Experimental (12 min Relaxation video clip) or Control (12 min SCD discussion) groups. Physiological markers and questionnaires (pain, stress) were completed before and after the intervention. Data were analyzed using the statistical software R.
All participants signing the consent completed the study; 93% of the 30 participants completed over 90% of the questionnaire items; 89% of control and 92% of experimental groups reported that the intervention was “Not hard at all;” and 83% of experimental group reported that they liked the intervention whereas 44% of control group did. Regression results controlling for baseline measure indicate a trend for positive relaxation intervention effects on pain (p = .09) and stress (p = .08). Relaxation indicators including respiration (p = .23), pulse (p = .79), and skin temperature (p = .60) were not significantly different between the two groups.
The study was feasible and the relaxation intervention was promising in reducing pain and stress. Future studies are warranted to test efficacy of the relaxation intervention and its mechanism in this population suffering with chronic disabling pain.
organization: University of Florida, United States
DOI: 10.1016/j.jpain.2017.12.083
read more
Related Content
-
Magnesium for treating sickle cell diseaseBACKGROUND: Sickle cell disease is an a...
-
Decreased hospital readmissions for vaso occlusive crisis with implementation of a Sickle Cell Pain Action Plan (SPA...Vaso occlusive crisis (VOC) is the most ...
-
Crizanlizumab designated FDA breakthrough therapy for potential in vaso-occlusive crisis preventionCrizanlizumab (SEG101), Novartis‘ inve...
-
New treatment plan leads to better pain control for acute sickle cell crisisThere’s new hope for the 70,000 to 80,...
-
CTX001 Continues to Show Promise in Severe SCDA single dose of CTX001, an experimental...
-
New Research Suggests SANGUINATE™ Reduces the Number of Sickled Red Blood Cells in Patients with Vaso-Occlusive Cr...SANGUINATE™, the only investigational ...
-
Phase 1 trial to test under-the-skin injection of sevuparin in sickle cell patientsModus Therapeutics is going to launch ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.